DrugInfoSys

Ethamsylate

Also known as: Cyclonamin, Etamsylate

Drug #1305

Ethamsylate hemostatic agent (prevents bleeding). Ethamsylate used to control surgical and menstrual blood loss.

Primary Characteristics

Ethamsylate is also known as Cyclonamin, Etamsylate.

It is of Synthetic origin and belongs to Sulphonates.

Molecular Weight: 263.3 · Solubility in Water: very soluble · Solubility in Alcohol: soluble · Non-proprietary name: Ethamsylate · pH: 4.5.

Molecular structure of Ethamsylate

Pharmacokinetics

Distribution: Ethamsylate has a plasma protein binding is 90%.

Elimination: plasma half-life is 8 hrs, renal excretion is Unchanged in urine.

Advertisement

Indications

Ethamsylate is primarily indicated in conditions like Haemorrhage, Short-term treatment of blood loss in menorrhagia.

Contraindications

None recorded.

Dosage

Ethamsylate's dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
500 mg500 mgEvery 4hFor short term blood loss in menorelagia
250 – 500 mgEvery 6hPOShould be given two to three days prior to surgery, with an additional 250 to 500 milligrams (mg) several hours prior to the procedure.
Paediatric Dosage (20kg)
No data.
Neonatal Dosage (3kg)
No data.

Drug Interactions

None recorded.

Side Effects

Ethamsylate in overdosage may give rise to further complications which include Hypotension , Hypotension .

Ethamsylate is known to cause more or less tolerable side effects which are usually transient. These include Headache, Nausea, Skin rashes.

Warnings / Precautions

Etamsylate is considered to be unsafe in patient with porphyria.

Available Brands

Click on a strength to view available brands.

Single Ingredient

Storage Conditions

Ethamsylate should be stored Tab, Inj.

Drug Classification

  1. 1.10.3Antihemorrhagics/Antihemophilics

Manufacturers

Manufacturers of Ethamsylate in Pakistan: